Showing results (201-210 of 438) with videos related to

Sort By:
Pageof 44
Clinical Cardiology|September 11, 2009
The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADEKevin M Takakuwa, Fang-Shu Ou, Eric D Peterson, et al.
American Heart Journal|July 29, 2008
Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromesChiara Melloni, Karen P Alexander, Anita Y Chen, et al.
American Heart Journal|July 6, 2010
Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trialChee Tang Chin, Matthew T Roe, Keith A A Fox, et al.
The American Journal of Cardiology|January 12, 2005
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarctionAjay J Kirtane, Aaron Weisbord, Dimitrios Karmpaliotis, et al.
JAMA|December 29, 2005
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromesKaren P Alexander, Anita Y Chen, Matthew T Roe, et al.
American Heart Journal|March 27, 2007
Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarctionMatthew T Roe, Abdul R Halabi, Rajendra H Mehta, et al.
European Heart Journal|August 22, 2008
Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromesMatthew T Roe, Fang-Shu Ou, Karen P Alexander, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 15, 2024
Predictors of outcomes after PCI with incomplete revascularization: Impact of CTO and LAD vesselToshiki Kuno, Giora Weisz, Philippe Généreux, et al.
American Heart Journal|November 5, 2021
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor doseC Michael Gibson, Michael J Mack, Victoria T Lee, et al.
JACC. Cardiovascular Interventions|April 20, 2010
Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines)Shailja V Parikh, James A de Lemos, Michael E Jessen, et al.
Pageof 44